Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for common male hair loss have limited effectiveness and can cause side effects.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

The conclusion suggests that treatments targeting root causes of chronic diseases may be developed by focusing on gene expression and lifestyle factors.

COVID-19 can cause hair loss, but specialists can help treat it.

Over 25% of COVID-19 patients had symptoms lasting more than a year.

The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

COVID-19 can cause temporary hair loss.

Covid-19 can cause hair loss due to immune and psychological factors.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Serum clusterin may play a key role in the inflammation and immune response in post-adolescent acne.

Drinking lots of sugary drinks may increase the risk of hair loss in young men.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

Inflammatory complications are rare after hair transplants but can happen months later, and checking for skin conditions before surgery is important.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

There might be a skin condition related to COVID-19.

A woman's hair grew back within 3 months after temporary hair loss from improper head positioning during shoulder surgery.

Hair transplantation is beneficial if the right patients are chosen and the procedure is done carefully.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Combination therapies work better than single treatments for atrophic acne scars.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Early changes in brain chemicals affect how a drug reduces alcohol intake in rats.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

A man developed a benign tumor at his COVID-19 vaccination site, which was successfully removed with surgery.